Subscribe to Newsletter

Business Practice

Business & Regulation Business Practice

Here Come the Humira Biosimilars

| Stephanie Vine | 2 min read

The first Humira biosimilar in the US is here, but market penetration could be a challenge.

Business & Regulation Business Practice

A Contentious Issue

| Stephanie Vine | 4 min read

Lawsuit from GenBioPro is the first of its kind – but other cases are likely to follow.

Business & Regulation Business Practice

Biotechs in the Baltic

| Angus Stewart | 12 min read

Snapshots, sketches, and secrets of Lithuania’s burgeoning life sciences scene.

Business & Regulation Business Practice

It’s a Material World…

| Angus Stewart | 2 min read

Growth, expansion, and acquisitions in Germany are on the menu for this global testing and safety company – here’s why

Business & Regulation Business Practice

Diversity Matters

| Stephanie Vine | 4 min read

It’s a fact that the pharma industry is dominated by white men. What does this mean for people from different ethnic backgrounds?

Business & Regulation Business Practice

Four Firm Favorites

| Stephanie Vine | 4 min read

From video games to climate change; looking back on a handful of articles from 2022.

Manufacture Advanced Medicine

Cell and Gene: Generating the Next Generation

| Angus Stewart | 4 min read

What can cell and gene do to avoid a seemingly inevitable rush on supporting products and services?

Business & Regulation Business Practice

A Tale of Two Inhibitors

| Angus Stewart | 4 min read

Two drugs, two different destinies. Does their story prove that business practice makes the difference?

Business & Regulation Business Practice

Between Two Worlds: Doing Business as a Cell and Gene Academic

| Stuart Curbishley | 6 min read

Pharma depends on academia, but that relationship can become better… and more fluid

Manufacture Advanced Medicine

The Cords that Bind

| Angus Stewart | 4 min read

Why critical starting materials are crucial to the production of cell and gene therapies, and among them cord blood deserves particular attention

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register